Rick Pauls | President and Chief Executive Officer |
Scott Kellen | Chief Financial Officer |
Thomas Flaten | Lake Street Capital |
Alex Nowak | Craig-Hallum |
Daniel Hultberg | Oppenheimer |
Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2023 Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investor Relations section.
Before the company proceeds with its remarks, please note that the company will be making forward-looking statements on today's call. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these statements.
More information, including factors that could cause actual results to differ from projected results appears in the section entitled Cautionary Note regarding forward-looking statements in the company's press release issued yesterday and under the heading Risk Factors in DiaMedica’s most recent annual Report on Form 10-K and subsequent quarterly report on Form 10-Q.